NovaBay Pharmaceuticals, Inc. to Present at the 25th Annual ROTH Conference

Published: Mar 12, 2013

EMERYVILLE, Calif., March 12, 2013 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biotechnology company focused on addressing a large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, today announced that Tom Paulson, Chief Financial Officer, will present at the 25th Annual ROTH Conference, held March 17-20, 2013, in Dana Point, California.

Back to news